200-Year-Old Heart Drug Linked To Increased Risk Of Death

Share this content:
200-Year-Old Heart Drug Linked To Increased Risk Of Death
200-Year-Old Heart Drug Linked To Increased Risk Of Death
Although it has a narrow therapeutic window and potentially dangerous interactions with other drugs, it is endorsed by current guidelines and widely given to patients with heart failure (HF) and atrial fibrillation (AF). However, there have been no randomized trials in AF and only one trial, the famous DIG trial, in HF.
READ FULL ARTICLE From Forbes
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »